-
3 Latin America Branded Generics Seller, Over-the-Counter Formulations Exporter and Oncology and Complex Generics Maker Stocks With a Strong Future Roadmap: Caplin Point Laboratories, Marksans Pharma and Natco Pharma
- October 27, 2026
- Posted by: Lakshit Sharma
- Category: Best Stocks
No Comments
Emerging Market, OTC and Cancer Drug Stocks with a strong future roadmap: Caplin Point Laboratories, Marksans Pharma and Natco Pharma. Compare price, valuation, return on equity and revenue growth as of 26 October 2026.
-
3 Branded Generics Marketer, Cardiac and Gastro Brands Company and Over-the-Counter Formulations Maker Stocks With a Strong Future Roadmap: Emcure Pharmaceuticals, JB Chemicals and Pharmaceuticals and Marksans Pharma
- October 27, 2026
- Posted by: Ankit Jaiswal
- Category: Best Stocks
Branded Generics, Cardiac and OTC Pharma Stocks with a strong future roadmap: Emcure Pharmaceuticals, JB Chemicals and Pharmaceuticals and Marksans Pharma. Compare price, valuation, return on equity and revenue growth as of 26 October 2026.
-
3 Over-the-Counter Formulations Exporter, Cardiovascular and CNS Brand Leader and Contract Manufacturing Specialist Stocks With a Strong Future Roadmap: Marksans Pharma, Torrent Pharmaceuticals and Innova Captab
- October 27, 2026
- Posted by: Ankit Jaiswal
- Category: Best Stocks
OTC, Specialty Brand and Contract Pharma Stocks with a strong future roadmap: Marksans Pharma, Torrent Pharmaceuticals and Innova Captab. Compare price, valuation, return on equity and revenue growth as of 26 October 2026.
-
3 Fermentation Based Ingredients Maker, Active Ingredients and Contract Research Company and OTC Medicines Producer Stocks With a Strong Future Roadmap: Concord Biotech, Laurus Labs and Marksans Pharma
- October 26, 2026
- Posted by: Ankit Jaiswal
- Category: Best Stocks
Fermentation API, Contract Pharma and OTC Stocks with a strong future roadmap: Concord Biotech, Laurus Labs and Marksans Pharma. Compare price, valuation, return on equity and revenue growth as of 23 October 2026.
-
3 Research-Driven Contract Manufacturer, Over-the-Counter Formulations Exporter and Point-of-Care Molecular Diagnostics Maker Stocks With a Strong Future Roadmap: Anthem Biosciences, Marksans Pharma and Molbio Diagnostics
- October 26, 2026
- Posted by: Ankit Jaiswal
- Category: Best Stocks
CDMO, OTC Pharma and Diagnostics Stocks with a strong future roadmap: Anthem Biosciences, Marksans Pharma and Molbio Diagnostics. Compare price, valuation, return on equity and revenue growth as of 23 October 2026.
-
3 Research-Driven Drug Maker, Complex Generics Supplier and Over-the-Counter Medicine Exporter Stocks With a Strong Future Roadmap: Glenmark Pharmaceuticals, Alembic Pharmaceuticals and Marksans Pharma
- October 26, 2026
- Posted by: Chaitanya Auti
- Category: Best Stocks
Branded Generics and Export Pharma Stocks with a strong future roadmap: Glenmark Pharmaceuticals, Alembic Pharmaceuticals and Marksans Pharma. Compare price, valuation, return on equity and revenue growth as of 23 October 2026.
-
3 Generic Pharma Exporter Stocks With a Strong Future Roadmap: Strides Pharma Science, Granules India and Marksans Pharma
- October 7, 2026
- Posted by: Kunal Singla
- Category: Best Stocks
Strides Pharma Science, Granules India and Marksans Pharma compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.